Ainos, Inc. (AIMD) vs Tvardi Therapeutics, Inc. (TVRD)
A side-by-side comparison of Ainos, Inc. and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIMD
Ainos, Inc.
$1.29HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TVRD
Tvardi Therapeutics, Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AIMD vs TVRD
growth of $100 · dividends reinvested · last 1yAIMD -44.6% (-44.6%/yr)TVRD -76.7% (-76.7%/yr)AIMD compounded faster over this window
AIMD TVRD
AIMD vs TVRD: by the numbers
- •TVRD is the larger company ($10M vs $10M market cap).
- •Both run net losses; TVRD's is the smaller (0.00% vs -106283.32% net margin).
Metrics side by side
Valuation
| Metric | AIMD | TVRD |
|---|---|---|
| P/S ratio | 698.55 | N/A |
| P/B ratio | 2.89 | 1.21 |
Profitability
| Metric | AIMD | TVRD |
|---|---|---|
| Gross margin | -3767.20% | 0.00% |
| Operating margin | -11268.32% | 0.00% |
| Net margin | -106283.32% | 0.00% |
| ROE | -440.15% | -310.94% |
| ROIC | -80.51% | -323.71% |
Growth (annualized)
| Metric | AIMD | TVRD |
|---|---|---|
| Revenue CAGR (5Y) | 49.62% | N/A |
| Total return CAGR (5Y) | -58.50% | N/A |
Go deeper
Dig into the metrics
Ainos ROETvardi Therapeutics ROEAinos operating marginTvardi Therapeutics operating marginAinos revenue growthTvardi Therapeutics revenue growthAinos free cash flowTvardi Therapeutics free cash flow
Ainos & Tvardi Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.